American Shared Hospital Services Reports 19.2% Revenue Growth in Q2 2026 Despite Increased Net Loss

American Shared Hospital Services (ASHS) reported its financial results for the second quarter and first half of 2026, revealing a total revenue of $8.43 million for the three months ending June 30, 2026, an increase of 19.2% from $7.07 million in the same period last year. For the six-month period, revenue rose to $15.51 million, up from $13.18 million in 2025. The growth was primarily driven by a significant increase in direct patient services revenue, which surged to $4.89 million for the quarter and $8.95 million for the half-year, compared to $3.50 million and $6.62 million, respectively, in the prior year. This increase was attributed to higher procedure volumes at the company's facilities in Rhode Island and Puebla, Mexico.

Despite the revenue growth, ASHS reported a net loss of $998,000 for the second quarter, compared to a loss of $478,000 in the same period of 2025. The loss for the first half of 2026 was $1.96 million, up from $1.39 million in the previous year. The increase in losses was largely due to higher operating costs, including a $909,000 increase in the allowance for credit losses related to the Rhode Island facilities, as well as legal fees associated with negotiating amendments to the company's credit agreements.

Operationally, ASHS has made strategic moves to enhance its service offerings and expand its market presence. The company operates seven Gamma Knife systems and one proton beam radiation therapy (PBRT) system across various locations, including facilities in the United States, Peru, Ecuador, and Mexico. The company also acquired a 60% equity interest in three radiation therapy facilities in Rhode Island in May 2024, which have contributed to the increase in direct patient services revenue. The number of PBRT fractions increased to 1,221 for the quarter, reflecting a 10% rise from the previous year, while Gamma Knife procedures also saw a slight increase.

In terms of financial health, ASHS reported cash, cash equivalents, and restricted cash of $6.76 million as of June 30, 2026, a notable increase from $3.71 million at the end of 2025. The company generated $4.39 million in cash from operating activities during the first half of the year. However, ASHS faces challenges with its long-term debt obligations, having entered into a Third Amendment with Fifth Third Bank to extend the maturity of its credit agreement to June 30, 2027, following non-compliance with certain covenants. The company is actively seeking to negotiate further extensions and is exploring options for additional financing to support its operations and commitments.

Looking ahead, ASHS remains focused on expanding its direct patient services segment and enhancing its operational efficiency. The company is committed to addressing its liquidity challenges and ensuring compliance with its financial covenants. Management has indicated that while the current financial landscape poses risks, they are optimistic about the potential for growth driven by increased procedure volumes and strategic investments in technology and facilities.